Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alfresa Holdings ( (JP:2784) ) has issued an announcement.
Alfresa Holdings reported a 4.9% increase in net sales for the quarter ending June 30, 2025, reaching ¥758,118 million, with a notable 12.9% rise in profit attributable to owners of the parent. Despite this growth, the company anticipates a decrease in profits for the fiscal year ending March 31, 2026, reflecting potential challenges in maintaining its current growth trajectory. The announcement highlights the company’s robust performance in the short term but indicates caution for the future, which may impact stakeholders’ expectations.
The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2120.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
Alfresa Holdings Corporation operates in the healthcare industry, primarily focusing on the distribution of pharmaceuticals, medical devices, and related services. The company is listed on the Prime Market of the Tokyo Stock Exchange and is a significant player in the Japanese healthcare market.
Average Trading Volume: 447,258
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen421.2B
See more insights into 2784 stock on TipRanks’ Stock Analysis page.